JMJD5 anticorps (AA 151-380) (FITC)
Aperçu rapide pour JMJD5 anticorps (AA 151-380) (FITC) (ABIN7157152)
Antigène
Voir toutes JMJD5 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 151-380
-
Réactivité croisée
- Humain
-
Purification
- >95%, Protein G purified
-
Immunogène
- Recombinant Human JmjC domain-containing protein 5 protein (151-380AA)
-
Isotype
- IgG
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- JMJD5 (Jumonji Domain Containing 5 (JMJD5))
-
Autre désignation
- KDM8
-
Sujet
-
Background: Histone demethylase required for G2/M phase cell cycle progression. Specifically demethylates dimethylated \\\'Lys-36\\\' (H3K36me2) of histone H3, an epigenetic repressive mark, thereby acting as a transcription activator. Regulates expression of CCNA1 (cyclin-A1), leading to regulate cancer cell proliferation.
Aliases: FLJ13798 antibody, JmjC domain-containing protein 5 antibody, JMJD5 antibody, JMJD5 protein antibody, jumonji domain containing 5 antibody, Jumonji domain-containing protein 5 antibody, KDM8_HUMAN antibody, Lysine (K) specific demethylase 8 antibody, Lysine-specific demethylase 8 antibody
-
UniProt
- Q8N371
-
Pathways
- Chromatin Binding
Antigène
-